Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the safety, tolerability and pharmacokinetics of
sequential ascending doses of JTK-853 administered for 14 days in healthy subjects and also
to determine the effect of a single dose of ketoconazole on the steady-state pharmacokinetic
profile of JTK-853 and its metabolite M2 (one cohort only).